Results 301 to 310 of about 3,808,290 (359)
Some of the next articles are maybe not open access.
European Journal of Haematology, 2001
Abstract: Acute basophilic leukemia has recently been included into a revised classification of acute leukemias proposed by the WHO panel. Due to the rarity of the disease, consistent diagnostic criteria are lacking. We report on two cases of acute basophilic leukemia that occurred in our department during the last 10 yr.
A A, Giagounidis +5 more
openaire +2 more sources
Abstract: Acute basophilic leukemia has recently been included into a revised classification of acute leukemias proposed by the WHO panel. Due to the rarity of the disease, consistent diagnostic criteria are lacking. We report on two cases of acute basophilic leukemia that occurred in our department during the last 10 yr.
A A, Giagounidis +5 more
openaire +2 more sources
Hematology/Oncology Clinics of North America, 2009
The evolution of acute myeloid leukemia (AML) classification reflects greater understanding of the AML pathogenesis. The 2008 World Health Organization classification incorporated cytogenetic and molecular genetic findings and introduced important prognostic correlations.
Amy, Heerema-McKenney, Daniel A, Arber
openaire +2 more sources
The evolution of acute myeloid leukemia (AML) classification reflects greater understanding of the AML pathogenesis. The 2008 World Health Organization classification incorporated cytogenetic and molecular genetic findings and introduced important prognostic correlations.
Amy, Heerema-McKenney, Daniel A, Arber
openaire +2 more sources
Acute megakaryoblastic leukemia
Blood, 2013![Figure][1] A 46-year-old woman presented with diffuse bone pain. She had a history of acute myeloid leukemia with minimal differentiation (AML-M0) and normal karyotype diagnosed 15 months ago, achieved complete remission (CR) 1 month after beginning induction chemotherapy, and received ...
Armin, Rashidi, Stephen I, Fisher
openaire +2 more sources
Advances in Therapy, 2011
Myelodysplastic syndromes (MDS) are a group of clonal cell disorders characterized by maturation defects, resulting in ineffective hematopoiesis. They often transform to acute myeloblastic leukemia (AML), which is difficult to treat and carries a dismal prognosis.
Carmen Avellaneda, Molina +3 more
openaire +2 more sources
Myelodysplastic syndromes (MDS) are a group of clonal cell disorders characterized by maturation defects, resulting in ineffective hematopoiesis. They often transform to acute myeloblastic leukemia (AML), which is difficult to treat and carries a dismal prognosis.
Carmen Avellaneda, Molina +3 more
openaire +2 more sources
Disease-a-Month, 2012
Hematological malignancies account for approximately 7% of new ancers annually. AML is the most common acute leukemia in adults. In 010, there were an estimated 12,330 new cases and 8950 deaths from ML. It accounts for about 80% of acute leukemias in adults. ALL had n estimated 5330 new cases and 1420 deaths in 2010.
Robert Frank, Cornell, Jeanne, Palmer
openaire +2 more sources
Hematological malignancies account for approximately 7% of new ancers annually. AML is the most common acute leukemia in adults. In 010, there were an estimated 12,330 new cases and 8950 deaths from ML. It accounts for about 80% of acute leukemias in adults. ALL had n estimated 5330 new cases and 1420 deaths in 2010.
Robert Frank, Cornell, Jeanne, Palmer
openaire +2 more sources
Pediatric Annals, 1983
During the past decade progress in the treatment of childhood acute lymphoblastic leukemia has slowed. A 50% to 60% cure barrier has frustrated a multitudinous array of therapeutic attempts to overcome this obstacle. With few exceptions, intensifications of induction, consolidation, or maintenance therapies have not overcome this obstacle.
openaire +2 more sources
During the past decade progress in the treatment of childhood acute lymphoblastic leukemia has slowed. A 50% to 60% cure barrier has frustrated a multitudinous array of therapeutic attempts to overcome this obstacle. With few exceptions, intensifications of induction, consolidation, or maintenance therapies have not overcome this obstacle.
openaire +2 more sources
Acute Leukemia: Diagnosis and Treatment.
Seminars in Oncology Nursing, 2019OBJECTIVE To provide an overview of acute leukemia, comparing incidence, presenting symptoms, diagnosis, prognosis, and treatment of the major subtypes.
L. Blackburn, Sarah Bender, S. Brown
semanticscholar +1 more source
The American Journal of Medicine, 1982
Abstract We examined the clinical features and therapeutic response of a group of patients with acute leukemia and hypocellular bone marrow. Therapists have generally avoided, delayed or modified therapy because of hypocellularity. We demonstrated not only that aggressive therapy is possible, but also that the remission rate is high (complete ...
R B, Howe, C D, Bloomfield, R W, McKenna
openaire +2 more sources
Abstract We examined the clinical features and therapeutic response of a group of patients with acute leukemia and hypocellular bone marrow. Therapists have generally avoided, delayed or modified therapy because of hypocellularity. We demonstrated not only that aggressive therapy is possible, but also that the remission rate is high (complete ...
R B, Howe, C D, Bloomfield, R W, McKenna
openaire +2 more sources
Pediatric Annals, 1978
Acute nonlymphoid leukemia (ANLL) is not an uncommon form of leukemia in children. The differential diagnosis is sometimes difficult, but there are a number of laboratory tests that can contribute useful information. Despite the introduction of several newer chemotherapeutic agents, only 50 to 60 percent of children with ANLL achieve complete ...
openaire +2 more sources
Acute nonlymphoid leukemia (ANLL) is not an uncommon form of leukemia in children. The differential diagnosis is sometimes difficult, but there are a number of laboratory tests that can contribute useful information. Despite the introduction of several newer chemotherapeutic agents, only 50 to 60 percent of children with ANLL achieve complete ...
openaire +2 more sources
Blood, 2014
![Figure][1] A 74-year-old woman consulted for asthenia that developed in the last few months. She had a history of acute myeloblastic leukemia (FAB/M6), which was treated 10 years ago and has been in complete remission since that time.
Marion, Eveillard +1 more
openaire +2 more sources
![Figure][1] A 74-year-old woman consulted for asthenia that developed in the last few months. She had a history of acute myeloblastic leukemia (FAB/M6), which was treated 10 years ago and has been in complete remission since that time.
Marion, Eveillard +1 more
openaire +2 more sources